NPCE NEUROPACE INC

NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference

NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference

MOUNTAIN VIEW, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference at 4:30pm PT (7:30pm ET) on Wednesday, January 15, 2025, in San Francisco, CA. Management will also host investor meetings during the conference.

The presentation will be accessible via live webcast . A webcast replay will be available for two weeks following the presentation in the section of NeuroPace’s Investor website at .

About NeuroPace, Inc.

Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.

Investor Contact:

Jeremy Feffer

Managing Director

LifeSci Advisors



EN
18/12/2024

Underlying

NPCENEUROPACE INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on NEUROPACE INC

 PRESS RELEASE
Free
NPCE NEUROPACE INC

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter a...

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates Preliminary unaudited revenue expected to be between $21.0 million and $21.5 million for Q4 2024, and between $79.4 million and $79.9 million for full year 2024 Scott Huennekens Appointed to NeuroPace Board of Directors effective January 6th Management presenting at the 43rd Annual J.P. Morgan Healthcare Conference on January 15th Company to host an Investor Day on January 28th in New York City MOUNTAIN VIEW, Calif., Jan. 08, 2025 (GLOBE NEWSWI...

January 8, 2025 1 EN
 PRESS RELEASE
Free
NPCE NEUROPACE INC

NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Confere...

NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference MOUNTAIN VIEW, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference at 4:30pm PT (7:30pm ET) on Wednesday, January 15, 2025, in San Francisco, CA. Management will also host investor meetings during the conference. The presentation will be accessible via live webcast . A webcast replay will be availab...

December 18, 2024 1 EN
 PRESS RELEASE
Free
NPCE NEUROPACE INC

NeuroPace to Host Investor Day on January 28th in New York City

NeuroPace to Host Investor Day on January 28th in New York City MOUNTAIN VIEW, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company will host an Investor Day from 9:00 a.m. – 12:00 p.m. ET on Tuesday, January 28, 2025 in New York City. The Investor Day will provide an update on NeuroPace’s vision for its unique RNS technology and will highlight the Company’s plans including presentations from management discussing NeuroPace’s recent results, fut...

December 12, 2024 1 EN
 PRESS RELEASE
Free
NPCE NEUROPACE INC

NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Soc...

NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting RNS System to be featured in over 70 scientific presentations and posters Pre-book a demonstration in the NeuroPace Tech Suite to see the latest innovations of the RNS System which simplify the treatment experience for physicians and patients NeuroPace’s Booth #2119 MOUNTAIN VIEW, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- December 4, 2024 – NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Comp...

December 4, 2024 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 48.56
MA MASTERCARD INCO...
RMAX RE/MAX Holdings... ... (+39)

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

MA MASTERCARD INCORPORATED
RMAX RE/MAX HOLDINGS INC.
OMER OMEROS CORPORATION
ELMD ELECTROMED
CRS CARPENTER TECHNOLOGY CORPORATION
CEVA CEVA INC.
AAOI APPLIED OPTOELECTRONICS INC.
SLM SLM CORP
UGI UGI CORPORATION
UTI UNIVERSAL TECHNICAL INSTITUTE INC.
MHH MASTECH DIGITAL
KINS KINGSTONE COS. INC.
PTGX PROTAGONIST THERAPEUTICS
TCMD TACTILE SYSTEMS TECHNOLOGY INC.
PDEX PRO-DEX INC.
FRMO FRMO CORPORATION
MMMB MAMAMANCINI'S HOLDINGS INC
REPL REPLIMUNE GROUP
BE BLOOM ENERGY
NEON NEONODE INC.
PWFL POWERFLEET INC
MRBK MERIDIAN
TPL TEXAS PACIFIC LAND CORPORATION
NPCE NEUROPACE INC
PLL PIEDMONT LITHIUM INC
SMR NUSCALE POWER CORP
RDW REDWIRE CORP
LUNR INTUITIVE MACHINES INC
HIPO HIPPO HLDGS INC
WGS GENEDX HOLDINGS CORP.
ASPI ASP ISOTOPES INC
AESI NEW ATLAS HOLDCO INC
NNE NANO NUCLEAR ENERGY
LB LANDBRIDGE COMPANY LLC
FOA FINANCE OF AMERICA COMPANIES INC.
DOGZ DOGNESS INTERNATIONAL CORP
TECX TD GLOBAL TECHNOLOGY LEADERS CAD HEDGED INDEX ETF
AZ A2Z CUST2MATE SOLUTIONS CORP
CDTX CIDARA THERAPEUTICS INC.
11/27/24 November 27, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch